These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 17314120

  • 1. Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis.
    Peters MJ, Vis M, van Halm VP, Wolbink GJ, Voskuyl AE, Lems WF, Dijkmans BA, Twisk JW, de Koning MH, van de Stadt RJ, Nurmohamed MT.
    Ann Rheum Dis; 2007 Jul; 66(7):958-61. PubMed ID: 17314120
    [Abstract] [Full Text] [Related]

  • 2. Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis.
    Vis M, Nurmohamed MT, Wolbink G, Voskuyl AE, de Koning M, van de Stadt R, Twisk JW, Dijkmans BA, Lems WF.
    J Rheumatol; 2005 Feb; 32(2):252-5. PubMed ID: 15693084
    [Abstract] [Full Text] [Related]

  • 3. Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis.
    Seriolo B, Paolino S, Sulli A, Fasciolo D, Cutolo M.
    Ann N Y Acad Sci; 2006 Jun; 1069():414-9. PubMed ID: 16855168
    [Abstract] [Full Text] [Related]

  • 4. Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy.
    Dahlqvist SR, Engstrand S, Berglin E, Johnson O.
    Scand J Rheumatol; 2006 Jun; 35(2):107-11. PubMed ID: 16641043
    [Abstract] [Full Text] [Related]

  • 5. Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.
    Cauza E, Cauza K, Hanusch-Enserer U, Etemad M, Dunky A, Kostner K.
    Wien Klin Wochenschr; 2002 Dec 30; 114(23-24):1004-7. PubMed ID: 12635469
    [Abstract] [Full Text] [Related]

  • 6. Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis.
    Kiortsis DN, Mavridis AK, Filippatos TD, Vasakos S, Nikas SN, Drosos AA.
    J Rheumatol; 2006 May 30; 33(5):921-3. PubMed ID: 16541480
    [Abstract] [Full Text] [Related]

  • 7. Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis.
    Allanore Y, Kahan A, Sellam J, Ekindjian OG, Borderie D.
    Clin Chim Acta; 2006 Mar 30; 365(1-2):143-8. PubMed ID: 16176811
    [Abstract] [Full Text] [Related]

  • 8. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis.
    García-Gómez C, Nolla JM, Valverde J, Gómez-Gerique JA, Castro MJ, Pintó X.
    J Rheumatol; 2009 Jul 30; 36(7):1365-70. PubMed ID: 19369465
    [Abstract] [Full Text] [Related]

  • 9. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.
    Spanakis E, Sidiropoulos P, Papadakis J, Ganotakis E, Katsikas G, Karvounaris S, Bizaki A, Kritikos H, Boumpas DT.
    J Rheumatol; 2006 Dec 30; 33(12):2440-6. PubMed ID: 17014005
    [Abstract] [Full Text] [Related]

  • 10. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
    García-Gómez C, Nolla JM, Valverde J, Narváez J, Corbella E, Pintó X.
    Eur J Clin Invest; 2008 Sep 30; 38(9):686-92. PubMed ID: 18837746
    [Abstract] [Full Text] [Related]

  • 11. Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis.
    Wolbink GJ, Voskuyl AE, Lems WF, de Groot E, Nurmohamed MT, Tak PP, Dijkmans BA, Aarden L.
    Ann Rheum Dis; 2005 May 30; 64(5):704-7. PubMed ID: 15485995
    [Abstract] [Full Text] [Related]

  • 12. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.
    Popa C, van den Hoogen FH, Radstake TR, Netea MG, Eijsbouts AE, den Heijer M, van der Meer JW, van Riel PL, Stalenhoef AF, Barrera P.
    Ann Rheum Dis; 2007 Nov 30; 66(11):1503-7. PubMed ID: 17472994
    [Abstract] [Full Text] [Related]

  • 13. Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis.
    van Halm VP, Nielen MM, Nurmohamed MT, van Schaardenburg D, Reesink HW, Voskuyl AE, Twisk JW, van de Stadt RJ, de Koning MH, Habibuw MR, van der Horst-Bruinsma IE, Dijkmans BA.
    Ann Rheum Dis; 2007 Feb 30; 66(2):184-8. PubMed ID: 16760255
    [Abstract] [Full Text] [Related]

  • 14. Lipid profiles among US elderly with untreated rheumatoid arthritis--the Third National Health and Nutrition Examination Survey.
    Choi HK, Seeger JD.
    J Rheumatol; 2005 Dec 30; 32(12):2311-6. PubMed ID: 16331755
    [Abstract] [Full Text] [Related]

  • 15. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients.
    Morris SJ, Wasko MC, Antohe JL, Sartorius JA, Kirchner HL, Dancea S, Bili A.
    Arthritis Care Res (Hoboken); 2011 Apr 30; 63(4):530-4. PubMed ID: 21452265
    [Abstract] [Full Text] [Related]

  • 16. Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study.
    Filippatos TD, Derdemezis CS, Voulgari PV, Tsimihodimos V, Elisaf MS, Tselepis AD, Drosos AA.
    Scand J Rheumatol; 2013 Apr 30; 42(3):169-75. PubMed ID: 23311768
    [Abstract] [Full Text] [Related]

  • 17. A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment.
    Durez P, Nzeusseu Toukap A, Lauwerys BR, Manicourt DH, Verschueren P, Westhovens R, Devogelaer JP, Houssiau FA.
    Ann Rheum Dis; 2004 Sep 30; 63(9):1069-74. PubMed ID: 15308515
    [Abstract] [Full Text] [Related]

  • 18. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis.
    Popa C, Netea MG, Radstake T, Van der Meer JW, Stalenhoef AF, van Riel PL, Barerra P.
    Ann Rheum Dis; 2005 Feb 30; 64(2):303-5. PubMed ID: 15231512
    [Abstract] [Full Text] [Related]

  • 19. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
    Shergy WJ, Isern RA, Cooley DA, Harshbarger JL, Huffstutter JE, Hughes GM, Spencer-Smith EA, Goldman AL, Roth SH, Toder JS, Warner D, Quinn A, Keenan GF, Schaible TF, PROMPT Study Group. Profiling Remicade Onset with MTX in a Prospective Trial.
    J Rheumatol; 2002 Apr 30; 29(4):667-77. PubMed ID: 11950005
    [Abstract] [Full Text] [Related]

  • 20. Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients.
    Popa C, van Tits LJ, Barrera P, Lemmers HL, van den Hoogen FH, van Riel PL, Radstake TR, Netea MG, Roest M, Stalenhoef AF.
    Ann Rheum Dis; 2009 Jun 30; 68(6):868-72. PubMed ID: 18635596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.